1. |
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis, 2024, 4: S1473-3099.
|
2. |
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2133-2161.
|
3. |
Safiri S, Mahmoodpoor A, Kolahi AA, et al. Global burden of lower respiratory infections during the last three decades. Front Public Health, 2023, 10: 1028525.
|
4. |
GBD 2019 LRI Collaborators. Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis, 2022, 22(11): 1626-1647.
|
5. |
GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2100-2132.
|
6. |
Lai CC, Chao CM, Hsueh PR. Clinical efficacy of antiviral agents against coronavirus disease 2019: a systematic review of randomized controlled trials. J Microbiol Immunol Infect, 2021, 54(5): 767-775.
|
7. |
World Health Organization. Calibrating long-term non-pharmaceutical interventions for COVID-19: principles and facilitation tools. 2023.
|
8. |
翁俊岭, 连代, 陶颖, 等. 非药物干预应用于COVID-19防控的卫生经济学评价的系统评价. 中国循证医学杂志, 2023, 23(6): 654-664.
|
9. |
Lee HH, Lin SH. Effects of COVID-19 prevention measures on other common infections, Taiwan. Emerg Infect Dis, 2020, 26(10): 2509-2511.
|
10. |
O'Toole RF. The interface between COVID-19 and bacterial healthcare-associated infections. Clin Microbiol Infect, 2021, 27(12): 1772-1776.
|
11. |
Stevens MP, Doll M, Pryor R, et al. Impact of COVID-19 on traditional healthcare-associated infection prevention efforts. Infect Control Hosp Epidemiol, 2020, 41(8): 946-947.
|
12. |
Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents, 2020, 55(3): 105924.
|
13. |
Zhou J, Zhao P, Nie M, et al. Changes of Haemophilus influenzae infection in children before and after the COVID-19 pandemic, Henan, China. J Infect, 2023, 86(1): 66-117.
|
14. |
Li Y, Guo Y, Duan Y. Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China. J Infect, 2022, 85(3): e80-e81.
|
15. |
Li L, Yu Z, Li M, et al. Changes of Acinetobacter baumannii infections in children before and after the COVID-19 pandemic in Zhengzhou, China. J Infect, 2023, 86(2): 154-225.
|
16. |
Lai CC, Chen SY, Ko WC, et al. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents, 2021, 57(4): 106324.
|
17. |
Ruan Z, Qi J, Qian ZM, et al. Disease burden and attributable risk factors of respiratory infections in China from 1990 to 2019. Lancet Reg Health West Pac, 2021, 11: 100153.
|
18. |
Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. Am J Transplant, 2020, 20(12): 3681-3685.
|
19. |
Ujiie M, Tsuzuki S, Nakamoto T, et al. Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg Infect Dis, 2021, 27(11): 2969-2970.
|
20. |
Munkstrup C, Lomholt FK, Emborg HD, et al. Early and intense epidemic of respiratory syncytial virus (RSV) in Denmark, August to December 2022. Euro Surveill, 2023, 28(1): 2200937.
|
21. |
Rybak A, Levy C, Angoulvant F, et al. Association of nonpharmaceutical interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France. JAMA Netw Open, 2022, 5(6): e2218959.
|
22. |
Li H, Zhou L, Zhao Y, et al. Epidemiological analysis of group a streptococcus infection diseases among children in Beijing, China under COVID-19 pandemic. BMC Pediatr, 2023, 23(1): 76.
|
23. |
Song SH, Lee H, Lee HJ, et al. Twenty-five year trend change in the etiology of pediatric invasive bacterial infections in Korea, 1996-2020. J Korean Med Sci, 2023, 38(16): e127.
|
24. |
Cohen R, Ashman M, Taha MK, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap. Infect Dis Now, 2021, 51(5): 418-423.
|
25. |
Polly M, de Almeida BL, Lennon RP, et al. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil. Am J Infect Control, 2022, 50(2): 238-239.
|
26. |
Bork JT, Leekha S, Claeys K, et al. Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019. Infect Control Hosp Epidemiol, 2021, 42(9): 1115-1117.
|
27. |
Tao S, Ru MY, Du W, et al. Quantifying the rural residential energy transition in China from 1992 to 2012 through a representative national survey. Nature Energy, 2014, 3: 567-573.
|
28. |
Wu MH, Liu YH, Xu ZC, et al. Spatio-temporal dynamics of China’s ecological civilization progress after implementing national conservation strategy. J Clean Prod, 2024, 285: 124886.
|
29. |
Gakidou E, Cowling K, Lozano R, et al. Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. Lancet, 2010, 376(9745): 959-974.
|
30. |
Grzywa-Celińska A, Krusiński A, Milanowski J. 'Smoging kills' - effects of air pollution on human respiratory system. Ann Agric Environ Med, 2020, 27(1): 1-5.
|
31. |
Flor LS, Anderson JA, Ahmad N, et al. Health effects associated with exposure to secondhand smoke: a Burden of Proof study. Nat Med, 2024, 30(1): 149-167.
|
32. |
Huttunen R, Heikkinen T, Syrjänen J. Smoking and the outcome of infection. J Intern Med, 2011, 269(3): 258-269.
|